Invaio Citrus Health
Commercial- Indications
- Citrus greening
Company intelligence / Profile preview
Invaio Sciences develops precision biotechnologies aimed at sustainable crop protection by targeting the microbiome within pest insects. Their approach seeks to reduce global pesticide use by modulating the health of pest species through their obligate microbial symbionts while sparing beneficial insects. The company leverages multidisciplinary expertise spanning human therapeutics, agriculture, environmental science, and advanced manufacturing. No clinical results are reported as they do not develop pharmaceuticals for humans or animals but rather ag-biotech solutions for crop health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Invaio Sciences.